TreeWAS – Variant ID: rs2484992

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Showing all nodes without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	No effect posterior probability	Protective posterior probability
C76-C80 Malignant neoplasms of ill-defined, secondary and unspecified sites	0.976	0.024
C15-C26 Malignant neoplasms of digestive organs	0.976	0.024
C78 Secondary malignant neoplasm of respiratory and digestive organs	0.976	0.024
C25 Malignant neoplasm of pancreas	0.977	0.022
C20 Malignant neoplasm of rectum	0.978	0.022
Chapter II Neoplasms	0.978	0.022
C79 Secondary malignant neoplasm of other sites	0.978	0.022
C78.6 Secondary malignant neoplasm of retroperitoneum and peritoneum	0.979	0.021
C78.7 Secondary malignant neoplasm of liver	0.979	0.021
C25.9 Pancreas, unspecified	0.980	0.020
C78.8 Secondary malignant neoplasm of other and unspecified digestive organs	0.980	0.020
C77 Secondary and unspecified malignant neoplasm of lymph nodes	0.980	0.020
C81-C96 Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue	0.981	0.019
C51-C58 Malignant neoplasms of female genital organs	0.981	0.019
C16 Malignant neoplasm of stomach	0.981	0.019
C15 Malignant neoplasm of oesophagus	0.981	0.019
C23 Malignant neoplasm of gallbladder	0.982	0.018
C21 Malignant neoplasm of anus and anal canal	0.982	0.018
C45-C49 Malignant neoplasms of mesothelial and soft tissue	0.982	0.018
C79.7 Secondary malignant neoplasm of adrenal gland	0.982	0.018
C25.1 Body of pancreas	0.982	0.018
C78.0 Secondary malignant neoplasm of lung	0.982	0.018
C79.5 Secondary malignant neoplasm of bone and bone marrow	0.982	0.018
D00-D09 In situ neoplasms	0.982	0.018
C17 Malignant neoplasm of small intestine	0.982	0.018
C25.0 Head of pancreas	0.982	0.017
C76 Malignant neoplasm of other and ill-defined sites	0.983	0.017
C22 Malignant neoplasm of liver and intrahepatic bile ducts	0.983	0.017
C80 Malignant neoplasm without specification of site	0.983	0.017
C25.2 Tail of pancreas	0.983	0.017
C18 Malignant neoplasm of colon	0.983	0.017
C78.4 Secondary malignant neoplasm of small intestine	0.983	0.017
C30-C39 Malignant neoplasms of respiratory and intrathoracic organs	0.983	0.017
C85 Other and unspecified types of non-Hodgkin's lymphoma	0.983	0.017
C79.8 Secondary malignant neoplasm of other specified sites	0.983	0.017
C78.3 Secondary malignant neoplasm of other and unspecified respiratory organs	0.983	0.017
C79.2 Secondary malignant neoplasm of skin	0.983	0.017
C26 Malignant neoplasm of other and ill-defined digestive organs	0.983	0.017
C24 Malignant neoplasm of other and unspecified parts of biliary tract	0.983	0.017
C25.7 Other parts of pancreas	0.983	0.017
D12 Benign neoplasm of colon, rectum, anus and anal canal	0.983	0.017
C40-C41 Malignant neoplasms of bone and articular cartilage	0.983	0.016
C79.9 Secondary malignant neoplasm, unspecified site	0.983	0.016
C78.2 Secondary malignant neoplasm of pleura	0.983	0.016
C78.1 Secondary malignant neoplasm of mediastinum	0.983	0.016
C79.0 Secondary malignant neoplasm of kidney and renal pelvis	0.983	0.016
C97-C97 Malignant neoplasms of independent (primary) multiple sites	0.983	0.016
C78.5 Secondary malignant neoplasm of large intestine and rectum	0.984	0.016
C25.8 Overlapping lesion of pancreas	0.984	0.016
D12.8 Rectum	0.984	0.016
C25.4 Endocrine pancreas	0.984	0.016
C91 Lymphoid leukaemia	0.984	0.016
C25.3 Pancreatic duct	0.984	0.016
C77.2 Intra-abdominal lymph nodes	0.984	0.016
C79.3 Secondary malignant neoplasm of brain and cerebral meninges	0.984	0.016
C19 Malignant neoplasm of rectosigmoid junction	0.984	0.016
D12.2 Ascending colon	0.984	0.016
C79.6 Secondary malignant neoplasm of ovary	0.984	0.016
C77.4 Inguinal and lower limb lymph nodes	0.984	0.016
C15.9 Oesophagus, unspecified	0.984	0.016
C56 Malignant neoplasm of ovary	0.984	0.016
C73-C75 Malignant neoplasms of thyroid and other endocrine glands	0.984	0.015
C79.4 Secondary malignant neoplasm of other and unspecified parts of nervous system	0.984	0.015
C79.1 Secondary malignant neoplasm of bladder and other and unspecified urinary organs	0.985	0.015
C16.5 Lesser curvature of stomach, unspecified	0.985	0.015
C77.8 Lymph nodes of multiple regions	0.985	0.015
C45 Mesothelioma	0.985	0.015
C64-C68 Malignant neoplasms of urinary tract	0.985	0.015
C77.9 Lymph node, unspecified	0.985	0.015
D04 Carcinoma in situ of skin	0.985	0.015
C85.9 Non-Hodgkin's lymphoma, unspecified type	0.985	0.015
D37-D48 Neoplasms of uncertain or unknown behaviour	0.985	0.015
C00-C14 Malignant neoplasms of lip, oral cavity and pharynx	0.985	0.015
D06 Carcinoma in situ of cervix uteri	0.985	0.015
C77.3 Axillary and upper limb lymph nodes	0.985	0.015
C83 Diffuse non-Hodgkin's lymphoma	0.985	0.014
C86 Other specified types of T/NK-cell lymphoma	0.985	0.014
C88 Malignant immunoproliferative diseases	0.986	0.014
C57 Malignant neoplasm of other and unspecified female genital organs	0.986	0.014
D10-D36 Benign neoplasms	0.986	0.014
C85.7 Other specified types of non-Hodgkin's lymphoma	0.986	0.014
C54 Malignant neoplasm of corpus uteri	0.986	0.014
C16.9 Stomach, unspecified	0.986	0.014
C95 Leukaemia of unspecified cell type	0.986	0.014
C53 Malignant neoplasm of cervix uteri	0.986	0.014
C52 Malignant neoplasm of vagina	0.986	0.014
C84 Peripheral and cutaneous T-cell lymphomas	0.986	0.014
C55 Malignant neoplasm of uterus, part unspecified	0.986	0.014
C51 Malignant neoplasm of vulva	0.986	0.014
C16.6 Greater curvature of stomach, unspecified	0.986	0.014
C60-C63 Malignant neoplasms of male genital organs	0.986	0.014
C96 Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue	0.986	0.014
C21.0 Anus, unspecified	0.986	0.014
C94 Other leukaemias of specified cell type	0.986	0.014
C93 Monocytic leukaemia	0.986	0.014
C16.0 Cardia	0.986	0.014
C77.5 Intrapelvic lymph nodes	0.986	0.014
C58 Malignant neoplasm of placenta	0.986	0.014
C69-C72 Malignant neoplasms of eye, brain and other parts of central nervous system	0.986	0.014
D07 Carcinoma in situ of other and unspecified genital organs	0.986	0.014
C90 Multiple myeloma and malignant plasma cell neoplasms	0.986	0.014
C16.8 Overlapping lesion of stomach	0.986	0.014
C16.4 Pylorus	0.986	0.014
C16.1 Fundus of stomach	0.986	0.014
C15.8 Overlapping lesion of oesophagus	0.986	0.013
C15.2 Abdominal part of oesophagus	0.986	0.013
C16.2 Body of stomach	0.986	0.013
C15.1 Thoracic part of oesophagus	0.986	0.013
C16.3 Pyloric antrum	0.986	0.013
C17.2 Ileum	0.986	0.013
C18.4 Transverse colon	0.986	0.013
C15.0 Cervical part of oesophagus	0.986	0.013
C15.5 Lower third of oesophagus	0.986	0.013
C81 Hodgkin's disease	0.986	0.013
C48 Malignant neoplasm of retroperitoneum and peritoneum	0.987	0.013
C15.3 Upper third of oesophagus	0.987	0.013
D12.4 Descending colon	0.987	0.013
C91.0 Acute lymphoblastic leukaemia	0.987	0.013
C80.0 Malignant neoplasm, primary site unknown, so stated	0.987	0.013
C82 Follicular [nodular] non-Hodgkin's lymphoma	0.987	0.013
C18.5 Splenic flexure	0.987	0.013
C77.1 Intrathoracic lymph nodes	0.987	0.013
D12.6 Colon, unspecified	0.987	0.013
C34 Malignant neoplasm of bronchus and lung	0.987	0.013
C49 Malignant neoplasm of other connective and soft tissue	0.987	0.013
C21.2 Cloacogenic zone	0.987	0.013
C46 Kaposi's sarcoma	0.987	0.013
C47 Malignant neoplasm of peripheral nerves and autonomic nervous system	0.987	0.013
C18.7 Sigmoid colon	0.987	0.013
C21.1 Anal canal	0.987	0.013
D00 Carcinoma in situ of oral cavity, oesophagus and stomach	0.987	0.013
C15.4 Middle third of oesophagus	0.987	0.013
C17.9 Small intestine, unspecified	0.987	0.013
C43-C44 Melanoma and other malignant neoplasms of skin	0.987	0.013
C21.8 Overlapping lesion of rectum, anus and anal canal	0.987	0.013
C22.9 Liver, unspecified	0.987	0.013
D12.3 Transverse colon	0.987	0.013
C76.0 Head, face and neck	0.987	0.013
C17.8 Overlapping lesion of small intestine	0.987	0.013
C17.3 Meckel's diverticulum	0.987	0.013
C18.8 Overlapping lesion of colon	0.987	0.013
D12.7 Rectosigmoid junction	0.987	0.013
C50-C50 Malignant neoplasm of breast	0.987	0.013
C31 Malignant neoplasm of accessory sinuses	0.987	0.013
C17.1 Jejunum	0.987	0.013
D12.5 Sigmoid colon	0.987	0.013
C41 Malignant neoplasm of bone and articular cartilage of other and unspecified sites	0.987	0.013
C26.9 Ill-defined sites within the digestive system	0.987	0.013
C92 Myeloid leukaemia	0.987	0.013
D02 Carcinoma in situ of middle ear and respiratory system	0.987	0.013
D01 Carcinoma in situ of other and unspecified digestive organs	0.987	0.013
C24.9 Biliary tract, unspecified	0.987	0.013
C76.8 Overlapping lesion of other and ill-defined sites	0.987	0.013
C76.7 Other ill-defined sites	0.987	0.013
C76.5 Lower limb	0.987	0.013
C76.4 Upper limb	0.987	0.013
C30 Malignant neoplasm of nasal cavity and middle ear	0.987	0.013
C22.7 Other specified carcinomas of liver	0.987	0.012
C22.4 Other sarcomas of liver	0.987	0.012
C22.3 Angiosarcoma of liver	0.987	0.012
C22.2 Hepatoblastoma	0.987	0.012
C38 Malignant neoplasm of heart, mediastinum and pleura	0.987	0.013
C22.1 Intrahepatic bile duct carcinoma	0.987	0.012
D12.9 Anus and anal canal	0.987	0.013
D09 Carcinoma in situ of other and unspecified sites	0.987	0.012
C18.1 Appendix	0.987	0.012
C76.2 Abdomen	0.987	0.012
C76.1 Thorax	0.987	0.012
C76.3 Pelvis	0.987	0.012
C17.0 Duodenum	0.987	0.012
D06.9 Cervix, unspecified	0.987	0.012
C39 Malignant neoplasm of other and ill-defined sites in the respiratory system and intrathoracic organs	0.987	0.012
C91.4 Hairy-cell leukaemia	0.987	0.012
C97 Malignant neoplasms of independent (primary) multiple sites	0.987	0.012
C85.0 Lymphosarcoma	0.988	0.012
C33 Malignant neoplasm of trachea	0.988	0.012
C18.6 Descending colon	0.988	0.012
C24.8 Overlapping lesion of biliary tract	0.988	0.012
C26.8 Overlapping lesion of digestive system	0.988	0.012
C26.1 Spleen	0.988	0.012
C85.2 Mediastinal (thymic) large B-cell lymphoma	0.988	0.012
C18.0 Caecum	0.988	0.012
C37 Malignant neoplasm of thymus	0.988	0.012
C22.0 Liver cell carcinoma	0.988	0.012
C32 Malignant neoplasm of larynx	0.988	0.012
D05 Carcinoma in situ of breast	0.988	0.012
C91.9 Lymphoid leukaemia, unspecified	0.988	0.012
C91.1 Chronic lymphocytic leukaemia	0.988	0.012
C42 hematopoietic and reticuloendothelial systems (ICD-O-3 specific)	0.988	0.012
C24.0 Extrahepatic bile duct	0.988	0.012
C24.1 Ampulla of Vater	0.988	0.012
C40 Malignant neoplasm of bone and articular cartilage of limbs	0.988	0.012
C77.0 Lymph nodes of head, face and neck	0.988	0.012
D04.3 Skin of other and unspecified parts of face	0.988	0.012
C45.7 Mesothelioma of other sites	0.988	0.012
D12.1 Appendix	0.988	0.012
C91.8 Mature B-cell leukaemia Burkitt-type	0.988	0.012
C91.7 Other lymphoid leukaemia	0.988	0.012
C91.6 Prolymphocytic leukaemia of T-cell type	0.988	0.012
C91.3 Prolymphocytic leukaemia	0.988	0.012
C91.2 Subacute lymphocytic leukaemia	0.988	0.012
C18.9 Colon, unspecified	0.988	0.012
C34.9 Bronchus or lung, unspecified	0.988	0.012
C91.5 Adult T-cell leukaemia	0.988	0.012
C45.9 Mesothelioma, unspecified	0.988	0.012
C80.9 Malignant neoplasm, unspecified	0.988	0.011
D33 Benign neoplasm of brain and other parts of central nervous system	0.988	0.012
C18.3 Hepatic flexure	0.988	0.011
C26.0 Intestinal tract, part unspecified	0.988	0.011
D04.5 Skin of trunk	0.988	0.011
C18.2 Ascending colon	0.988	0.011
C85.1 B-cell lymphoma, unspecified	0.988	0.011
D04.6 Skin of upper limb, including shoulder	0.988	0.011
D38 Neoplasm of uncertain or unknown behaviour of middle ear and respiratory and intrathoracic organs	0.989	0.011
C83.8 Other types of diffuse non-Hodgkin's lymphoma	0.989	0.011
D28 Benign neoplasm of other and unspecified female genital organs	0.989	0.011
D37 Neoplasm of uncertain or unknown behaviour of oral cavity and digestive organs	0.989	0.011
C73 Malignant neoplasm of thyroid gland	0.989	0.011
C83.0 Small cell (diffuse)	0.989	0.011
D03 Melanoma in situ	0.989	0.011
D16 Benign neoplasm of bone and articular cartilage	0.989	0.011
C08 Malignant neoplasm of other and unspecified major salivary glands	0.989	0.011
C45.0 Mesothelioma of pleura	0.989	0.011
C75 Malignant neoplasm of other endocrine glands and related structures	0.989	0.011
C74 Malignant neoplasm of adrenal gland	0.989	0.011
D29 Benign neoplasm of male genital organs	0.989	0.011
D07.1 Vulva	0.989	0.011
C68 Malignant neoplasm of other and unspecified urinary organs	0.989	0.011
C54.1 Endometrium	0.989	0.011
D04.2 Skin of ear and external auricular canal	0.989	0.011
D39 Neoplasm of uncertain or unknown behaviour of female genital organs	0.989	0.011
C67 Malignant neoplasm of bladder	0.989	0.011
C65 Malignant neoplasm of renal pelvis	0.989	0.011
D44 Neoplasm of uncertain or unknown behaviour of endocrine glands	0.989	0.011
C45.2 Mesothelioma of pericardium	0.989	0.011
C86.5 Angioimmunoblastic T-cell lymphoma	0.989	0.011
C01 Malignant neoplasm of base of tongue	0.989	0.011
C45.1 Mesothelioma of peritoneum	0.989	0.011
C57.9 Female genital organ, unspecified	0.989	0.011
D25 Leiomyoma of uterus	0.989	0.011
C88.4 Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lymphoma]	0.989	0.011
D04.8 Skin of other sites	0.989	0.011
D34 Benign neoplasm of thyroid gland	0.989	0.011
C83.9 Diffuse non-Hodgkin's lymphoma, unspecified	0.989	0.011
C06 Malignant neoplasm of other and unspecified parts of mouth	0.989	0.011
C04 Malignant neoplasm of floor of mouth	0.989	0.011
D14 Benign neoplasm of middle ear and respiratory system	0.989	0.011
C83.1 Small cleaved cell (diffuse)	0.989	0.011
D04.0 Skin of lip	0.989	0.011
C05 Malignant neoplasm of palate	0.989	0.011
D04.7 Skin of lower limb, including hip	0.989	0.011
C51.9 Vulva, unspecified	0.989	0.011
C57.0 Fallopian tube	0.989	0.011
D04.9 Skin, unspecified	0.989	0.011
D04.1 Skin of eyelid, including canthus	0.989	0.011
D42 Neoplasm of uncertain or unknown behaviour of meninges	0.989	0.011
D06.7 Other parts of cervix	0.989	0.011
C95.9 Leukaemia, unspecified	0.989	0.010
D06.1 Exocervix	0.989	0.010
D43 Neoplasm of uncertain or unknown behaviour of brain and central nervous system	0.989	0.010
D41 Neoplasm of uncertain or unknown behaviour of urinary organs	0.989	0.011
D40 Neoplasm of uncertain or unknown behaviour of male genital organs	0.989	0.010
C53.0 Endocervix	0.989	0.010
C13 Malignant neoplasm of hypopharynx	0.989	0.010
C83.6 Undifferentiated (diffuse)	0.989	0.010
C83.4 Immunoblastic (diffuse)	0.989	0.010
C88.0 Waldenstrom's macroglobulinaemia	0.989	0.010
D06.0 Endocervix	0.989	0.010
C11 Malignant neoplasm of nasopharynx	0.989	0.010
C03 Malignant neoplasm of gum	0.989	0.010
C83.5 Lymphoblastic (diffuse)	0.989	0.010
C83.2 Mixed small and large cell (diffuse)	0.989	0.010
C00 Malignant neoplasm of lip	0.989	0.010
C84.4 Peripheral T-cell lymphoma	0.989	0.010
C86.6 Primary cutaneous CD30-positive T-cell proliferations	0.989	0.010
C86.4 Blastic NK-cell lymphoma	0.989	0.010
C86.3 Subcutaneous panniculitis-like T-cell lymphoma	0.989	0.010
C86.2 Enteropathy-type (intestinal) T-cell lymphoma	0.989	0.010
C86.1 Hepatosplenic T-cell lymphoma	0.989	0.010
C86.0 Extranodal NK/T-cell lymphoma, nasal type	0.989	0.010
C88.9 Malignant immunoproliferative disease, unspecified	0.989	0.010
C88.7 Other malignant immunoproliferative diseases	0.989	0.010
C88.3 Immunoproliferative small intestinal disease	0.989	0.010
C88.2 Gamma heavy chain disease	0.989	0.010
C88.1 Alpha heavy chain disease	0.989	0.010
C12 Malignant neoplasm of pyriform sinus	0.989	0.010
D04.4 Skin of scalp and neck	0.989	0.010
C14 Malignant neoplasm of other and ill-defined sites in the lip, oral cavity and pharynx	0.989	0.010
C84.5 Other and unspecified T-cell lymphomas	0.989	0.010
C57.7 Other specified female genital organs	0.989	0.010
C57.4 Uterine adnexa, unspecified	0.989	0.010
C57.3 Parametrium	0.989	0.010
C57.2 Round ligament	0.989	0.010
C57.1 Broad ligament	0.989	0.010
C10 Malignant neoplasm of oropharynx	0.989	0.010
D19 Benign neoplasm of mesothelial tissue	0.989	0.010
D30 Benign neoplasm of urinary organs	0.989	0.010
C53.9 Cervix uteri, unspecified	0.989	0.010
C54.8 Overlapping lesion of corpus uteri	0.989	0.010
C54.3 Fundus uteri	0.989	0.010
C54.2 Myometrium	0.989	0.010
C54.0 Isthmus uteri	0.989	0.010
D20 Benign neoplasm of soft tissue of retroperitoneum and peritoneum	0.989	0.010
C57.8 Overlapping lesion of female genital organs	0.989	0.010
C83.7 Burkitt's tumour	0.989	0.010
C02 Malignant neoplasm of other and unspecified parts of tongue	0.989	0.010
D18 Haemangioma and lymphangioma, any site	0.989	0.010
C66 Malignant neoplasm of ureter	0.989	0.010
C84.9 Mature T/NK-cell lymphoma, unspecified	0.989	0.010
C84.7 Anaplastic large cell lymphoma, ALK-negative	0.989	0.010
C84.6 Anaplastic large cell lymphoma, ALK-positive	0.989	0.010
C84.3 Lymphoepithelioid lymphoma	0.989	0.010
C84.2 T-zone lymphoma	0.989	0.010
C84.1 Sezary's diease	0.989	0.010
C95.7 Other leukaemia of unspecified cell type	0.989	0.010
C95.2 Subacute leukaemia of unspecified cell type	0.989	0.010
C60 Malignant neoplasm of penis	0.989	0.010
C53.8 Overlapping lesion of cervix uteri	0.989	0.010
C53.1 Exocervix	0.989	0.010
C51.8 Overlapping lesion of vulva	0.990	0.010
C51.2 Clitoris	0.990	0.010
C95.1 Chronic leukaemia of unspecified cell type	0.990	0.010
C95.0 Acute leukaemia of unspecified cell type	0.990	0.010
C07 Malignant neoplasm of parotid gland	0.990	0.010
C51.1 Labium minus	0.990	0.010
C84.8 Cutaneous T-cell lymphoma, unspecified	0.990	0.010
D45 Polycythaemia vera	0.990	0.010
C51.0 Labium majus	0.990	0.010
C96.9 Malignant neoplasms of lymphoid, haematopoietic and related tissue, unspecified	0.990	0.010
C96.8 Histiocytic sarcoma	0.990	0.010
C96.7 Other specified malignant neoplasms of lymphoid, haematopoietic and related tissue	0.990	0.010
C96.6 Unifocal Langerhans-cell histiocytosis	0.990	0.010
C96.5 Multifocal and unisystemic Langerhans-cell histiocytosis	0.990	0.010
C96.4 Sarcoma of dendritic cells (accessory cells)	0.990	0.010
C96.3 True histiocytic lymphoma	0.990	0.010
C96.2 Malignant mast cell tumour	0.990	0.010
C96.1 Malignant histiocytosis	0.990	0.010
C96.0 Letterer-Siwe disease	0.990	0.010
D07.2 Vagina	0.990	0.010
C63 Malignant neoplasm of other and unspecified male genital organs	0.990	0.010
C54.9 Corpus uteri, unspecified	0.990	0.010
C69 Malignant neoplasm of eye and adnexa	0.990	0.010
C84.0 Mycosis fungoides	0.990	0.010
C94.7 Other specified leukaemias	0.990	0.010
C94.5 Acute myelofibrosis	0.990	0.010
C94.3 Mast cell leukaemia	0.990	0.010
C94.2 Acute megakaryoblastic leukaemia	0.990	0.010
C94.1 Chronic erythraemia	0.990	0.010
C94.0 Acute erythraemia and erythroleukaemia	0.990	0.010
C93.9 Monocytic leukaemia, unspecified	0.990	0.010
C93.7 Other monocytic leukaemia	0.990	0.010
C93.3 Juvenile myelomonocytic leukaemia	0.990	0.010
C93.2 Subacute monocytic leukaemia	0.990	0.010
C93.0 Acute monocytic leukaemia	0.990	0.010
C94.4 Acute panmyelosis	0.990	0.010
D36 Benign neoplasm of other and unspecified sites	0.990	0.010
D15 Benign neoplasm of other and unspecified intrathoracic organs	0.990	0.010
C94.6 Myelodysplastic and myeloproliferative disease, not elsewhere classified	0.990	0.010
C09 Malignant neoplasm of tonsil	0.990	0.010
C90.0 Multiple myeloma	0.990	0.010
D24 Benign neoplasm of breast	0.990	0.010
C93.1 Chronic monocytic leukaemia	0.990	0.010
D46 Myelodysplastic syndromes	0.990	0.010
C48.2 Peritoneum, unspecified	0.990	0.010
D21 Other benign neoplasms of connective and other soft tissue	0.990	0.010
D07.6 Other and unspecified male genital organs	0.990	0.010
D31 Benign neoplasm of eye and adnexa	0.990	0.010
D07.3 Other and unspecified female genital organs	0.990	0.010
D07.0 Endometrium	0.990	0.010
C72 Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system	0.990	0.010
C70 Malignant neoplasm of meninges	0.990	0.010
D05.1 Intraductal carcinoma in situ	0.990	0.010
C48.1 Specified parts of peritoneum	0.990	0.010
C90.1 Plasma cell leukaemia	0.990	0.010
C81.1 Nodular sclerosis	0.990	0.010
C90.3 Solitary plasmacytoma	0.990	0.010
D47 Other neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue	0.990	0.010
C41.1 Mandible	0.990	0.010
C82.1 Mixed small cleaved and large cell, follicular	0.990	0.010
D07.4 Penis	0.990	0.010
D11 Benign neoplasm of major salivary glands	0.990	0.010
C49.9 Connective and soft tissue, unspecified	0.990	0.010
C81.4 Lymphocyte-rich classical Hodgkin lymphoma	0.990	0.010
C81.3 Lymphocytic depletion	0.990	0.010
C49.0 Connective and soft tissue of head, face and neck	0.990	0.010
C49.3 Connective and soft tissue of thorax	0.990	0.010
C48.8 Overlapping lesion of retroperitoneum and peritoneum	0.990	0.010
D00.0 Lip, oral cavity and pharynx	0.990	0.010
C81.7 Other Hodgkin's disease	0.990	0.010
C81.2 Mixed cellularity	0.990	0.010
C81.0 Lymphocytic predominance	0.990	0.010
D07.5 Prostate	0.990	0.010
C64 Malignant neoplasm of kidney, except renal pelvis	0.990	0.010
C82.6 Cutaneous follicle centre lymphoma	0.990	0.010
C82.5 Diffuse follicle centre lymphoma	0.990	0.010
C90.2 Plasmacytoma, extramedullary	0.990	0.010
D33.3 Cranial nerves	0.990	0.010
D10 Benign neoplasm of mouth and pharynx	0.990	0.010
C31.0 Maxillary sinus	0.990	0.010
C49.8 Overlapping lesion of connective and soft tissue	0.990	0.009
C82.4 Follicular lymphoma grade IIIb	0.990	0.009
D48 Neoplasm of uncertain or unknown behaviour of other and unspecified sites	0.990	0.010
C46.9 Kaposi's sarcoma, unspecified	0.990	0.009
C46.8 Kaposi's sarcoma of multiple organs	0.990	0.009
C46.7 Kaposi's sarcoma of other sites	0.990	0.009
C46.3 Kaposi's sarcoma of lymph nodes	0.990	0.009
C46.2 Kaposi's sarcoma of palate	0.990	0.009
C46.1 Kaposi's sarcoma of soft tissue	0.990	0.009
C46.0 Kaposi's sarcoma of skin	0.990	0.009
C48.0 Retroperitoneum	0.990	0.009
C47.9 Peripheral nerves and autonomic nervous system, unspecified	0.990	0.009
C47.8 Overlapping lesion of peripheral nerves and autonomic nervous system	0.990	0.009
C47.6 Peripheral nerves of trunk, unspecified	0.990	0.009
C47.5 Peripheral nerves of pelvis	0.990	0.009
C47.4 Peripheral nerves of abdomen	0.990	0.009
C47.3 Peripheral nerves of thorax	0.990	0.009
C47.2 Peripheral nerves of lower limb, including hip	0.990	0.009
C47.0 Peripheral nerves of head, face and neck	0.990	0.009
C82.3 Follicular lymphoma grade IIIa	0.990	0.009
C62 Malignant neoplasm of testis	0.990	0.009
C41.0 Bones of skull and face	0.990	0.009
C49.6 Connective and soft tissue of trunk, unspecified	0.990	0.009
C49.2 Connective and soft tissue of lower limb, including hip	0.990	0.009
D00.2 Stomach	0.990	0.009
C34.8 Overlapping lesion of bronchus and lung	0.990	0.009
C47.1 Peripheral nerves of upper limb, including shoulder	0.990	0.009
C49.4 Connective and soft tissue of abdomen	0.990	0.009
C82.2 Large cell, follicular	0.990	0.009
C82.0 Small cleaved cell, follicular	0.990	0.009
D26 Other benign neoplasms of uterus	0.990	0.009
C49.5 Connective and soft tissue of pelvis	0.990	0.009
D00.1 Oesophagus	0.990	0.009
C38.4 Pleura	0.990	0.009
C30.0 Nasal cavity	0.990	0.009
C82.9 Follicular non-Hodgkin's lymphoma, unspecified	0.990	0.009
C82.7 Other types of follicular non-Hodgkin's lymphoma	0.990	0.009
C49.1 Connective and soft tissue of upper limb, including shoulder	0.990	0.009
C34.0 Main bronchus	0.990	0.009
D32 Benign neoplasm of meninges	0.990	0.009
C81.9 Hodgkin's disease, unspecified	0.990	0.009
C92.1 Chronic myeloid leukaemia	0.990	0.009
C31.9 Accessory sinus, unspecified	0.991	0.009
C31.8 Overlapping lesion of accessory sinuses	0.991	0.009
C31.3 Sphenoidal sinus	0.991	0.009
C31.2 Frontal sinus	0.991	0.009
C31.1 Ethmoidal sinus	0.991	0.009
C41.8 Overlapping lesion of bone and articular cartilage	0.991	0.009
C34.3 Lower lobe, bronchus or lung	0.991	0.009
C41.3 Ribs, sternum and clavicle	0.991	0.009
C92.8 Acute myeloid leukaemia with multilineage dysplasia	0.991	0.009
C92.6 Acute myeloid leukaemia with 11q23-abnormality	0.991	0.009
C92.3 Myeloid sarcoma	0.991	0.009
C41.2 Vertebral column	0.991	0.009
D01.9 Digestive organ, unspecified	0.991	0.009
D01.7 Other specified digestive organs	0.991	0.009
D01.4 Other and unspecified parts of intestine	0.991	0.009
D01.1 Rectosigmoid junction	0.991	0.009
D02.4 Respiratory system, unspecified	0.991	0.009
D02.3 Other parts of respiratory system	0.991	0.009
D02.1 Trachea	0.991	0.009
C92.2 Subacute myeloid leukaemia	0.991	0.009
C30.1 Middle ear	0.991	0.009
C38.8 Overlapping lesion of heart, mediastinum and pleura	0.991	0.009
C38.2 Posterior mediastinum	0.991	0.009
C38.1 Anterior mediastinum	0.991	0.009
C38.0 Heart	0.991	0.009
C41.4 Pelvic bones, sacrum and coccyx	0.991	0.009
C92.5 Acute myelomonocytic leukaemia	0.991	0.009
D01.5 Liver, gallbladder and bile ducts	0.991	0.009
C34.2 Middle lobe, bronchus or lung	0.991	0.009
C41.9 Bone and articular cartilage, unspecified	0.991	0.009
C92.9 Myeloid leukaemia, unspecified	0.991	0.009
D02.2 Bronchus and lung	0.991	0.009
C83.3 Large cell (diffuse)	0.991	0.009
C92.7 Other myeloid leukaemia	0.991	0.009
C38.3 Mediastinum, part unspecified	0.991	0.009
D01.2 Rectum	0.991	0.009
D01.0 Colon	0.991	0.009
D09.3 Thyroid and other endocrine glands	0.991	0.009
D09.2 Eye	0.991	0.009
C92.4 Acute promyelocytic leukaemia	0.991	0.009
D05.7 Other carcinoma in situ of breast	0.991	0.009
D09.7 Carcinoma in situ of other specified sites	0.991	0.009
C61 Malignant neoplasm of prostate	0.991	0.009
D01.3 Anus and anal canal	0.991	0.009
D09.9 Carcinoma in situ, unspecified	0.991	0.009
D35 Benign neoplasm of other and unspecified endocrine glands	0.991	0.009
D12.0 Caecum	0.991	0.009
C39.9 Ill-defined sites within the respiratory system	0.991	0.009
C39.8 Overlapping lesion of respiratory and intrathoracic organs	0.991	0.009
C39.0 Upper respiratory tract, part unspecified	0.991	0.009
D09.1 Other and unspecified urinary organs	0.991	0.009
D28.0 Vulva	0.991	0.009
C32.0 Glottis	0.991	0.009
C32.1 Supraglottis	0.991	0.009
D02.0 Larynx	0.991	0.009
D25.0 Submucous leiomyoma of uterus	0.991	0.009
D09.0 Bladder	0.991	0.009
C32.8 Overlapping lesion of larynx	0.991	0.009
C32.3 Laryngeal cartilage	0.991	0.009

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations